link the global retroperitoneal liposarcoma treatment market is expected to exhibit a moderate growth rate owing to low incidence of this disease across the globe retroperitoneal liposarcoma rls is a rare biologically heterogeneous cancer which occurs in retroperitoneum lining of the abdominal space that covers the abdominal organs retroperitoneal liposarcoma grow continuously and may not get diagnosed until they are very large thus its prognosis is poor compared to the other subtypes of retroperitoneal sarcomas the reason for the development of these tumors are still unknown however genetic mutation is considered to be one of the factors leading to the generation of these tumors incidence of this disease is equal in men and women with a slight predominance of men this tumor has no characteristic symptoms and are usually diagnosed during the advanced stage click to continue reading on link furthermore the effectiveness of radiotherapy or chemotherapy for the treatment of this tumor is not properly defined as they are massive in size and might involve adjacent visceral organs and critical structures however affected population who received adjuvant chemotherapy showed survival benefits and improvement as compared to patients who underwent surgery alone in the case of surgeries sometimes preoperative radiation is given to shrink the tumor this allows smaller doses of radiation to a smaller field and make the surgery technically more feasible the european organisation for research and treatment of cancer eortc is currently conducting a randomized trial comparing gy gray unit to measure radiation therapy of pre operative radiation therapy with short course radiotherapy followed by surgery to direct surgery alone thus continuous researches that are being conducted for the development of treatment for this disease is expected to create lucrative opportunities in the retroperitoneal liposarcoma treatment market during the forecast period request sample copy of this business report link key vendors eli lilly and company baxter international bristol laboratories ltd pfizer inc teva pharmaceutical industries ltd mylan n v actavis plc fresenius kabi ltd accord healthcare inc taro pharmaceuticals inc sandoz bedford laboratories and zydus cadila contact us mr shahlink coherent market insightslink th ave link seattlelink wa link tel link email link visit blog link source link from articlesfactory com about coherent market insights coherent market insights is a prominent market research and consulting firm offering action ready syndicated research reports custom market analysis consulting services and competitive analysis through various recommendations related to emerging market trends technologies and potential absolute dollar opportunity 